Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $505.0000 (-3.81%) ($300.0000 - $650.0000) on Thu. Dec. 18, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 16.62% (three month average) | RSI | 57 | Latest Price | $505.0000(-3.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 23.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -8.31% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(-0%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -8.31% (StdDev 16.62%) | Hourly BBV | 0 () | Intraday Trend | -22.3% | | | |
|
5 Day Moving Average | $516.01(-2.13%) | 10 Day Moving Average | $407.04(24.07%) | 20 Day Moving Average | $407.43(23.95%) | To recent high | -80.2% | To recent low | 140.5% | Market Cap | $9.947b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |